The company is consistently working to develop innovative and green solutions based on microbiology
Born 1985. Chief Executive Officer since 2023
Member of management team since 2018. Edvard Hall holds a law degree and a bachelor’s degree in economics from Lund University as well as an MSc International Development and Humanitarian Emergencies from London School of Economics and Political Science. Edvard Hall has a background from a law firm and as a management consultant, entrepreneur and investor with experience in building, running and developing innovative companies in the field of sustainability. Edvard Hall has previously co-founded and run companies active in narrative analysis, strategy advice and medical technology.
Other ongoing assignments: Chairman ProLevi Bio AB. Board member of Diagonal Bio AB, Parlametric AB and Könyves Invest AB.
Holdings in the Company: 516,826 shares and 300,000 TO 2023/2026.
Born 1982. Chief Financial Officer since 2023.
Kristofer Svensson holds a bachelor’s degree in economics from Stockholm University. Kristofer has several years of experience from financial executive positions as CFO, primarily within the healthcare sector. Kristofer Svensson has ongoing assignments as CFO at Gabather (publ), Ectin Research (publ) and Sinfonia Biotherapeutics. Previous assignment includes CFO at Sensidose (publ) and Melius pharma.
Other ongoing assignments: Board member of K Svensson Consulting AB.
Holdings in the Company: 0 shares, 75,000 warrants.
Born 1971. Chief Operating Officer since 2022.
Klas Ingstorp holds a Master of Science in Chemical Engineering from Lund University. Klas Ingstorp has more than 25 years of experience from the process chemistry company Perstorp and has, among other things, been active as factory manager for special polyol manufacturing, site manager for feed additive production, head of global Perstorp Engineering groups and responsible for EHS–Q (Enviroment, Health, Safety and Quality Systems) within Perstorp Global Technology.
Other ongoing assignments: Deputy board member of Dr. Ingstorp Consulting AB.
Holdings in the Company: 22,340 shares, 250 000 TO 2022/2025 I and 7,740 TO3.
Born 1963. Chairperson since 2022.
Mats Persson holds a Master of Science in Chemical Engineering from Lund University. Mats Persson’s previous positions include several senior positions within the Perstorp Group, including deputy CEO. In addition, Mats Persson has worked as Chief Operating Officer at the composite manufacturer Diab with responsibility for, among other things, manufacturing and logistics.
Other ongoing assignments: Chairman of the Board of CirChem AB. Deputy Board member of the Housing Association Pilstorp.
Holdings in the Company: 120,833 shares and 250,000 TO 2022/2025 II, 150,000 TO 2023/2026 II.
Independent in relation to the company, company management and its major shareholders.
Born 1970. Board member since 2024. Marie
Marie Grönborg holds a Master of Science in Chemical Engineering. Grönborg has 30 years of experience in various industrial sectors, primarily focused on the chemical industry. Grönborg spent 25 years at Perstorp Group, where she held key positions, including Executive Vice President Global Innovation and Business Area Specialties & Solutions . Most recently, Grönborg acted as the CEO of Purac and Tree To Textile.
Other ongoing assignments: Marie serves on several boards, including Lantmännen, SSAB AB, Eolus Vind AB, and Aduro Clean Technologies Inc.
Born 1959. Board member since 2019.
Håkan Björnberg holds a Master of Science in Chemical Engineering from Lund University. Håkan Björnberg has 40 years of experience from research and development work as well as business development in the chemical industry and a long experience of commercializing innovations. Recently Håkan Björnberg was Vice President Innovation at Perstorp AB and responsible for the business development and Innovation of Perstorp’s strategic markets including plastics, paints, synthetic lubricants and additives for animal feed. Håkan currently has a senior advisory position at Perstorp AB.
Other ongoing assignments: –
Holdings in the Company: 17,168 shares.
Independent in relation to the company, company management and its major shareholders.
Born 1974. Board member since 2021.
Fredrik Sjödin holds a Master of Science in Business and Economics from the Stockholm School of Economics. Fredrik Sjödin has extensive experience of investments and board assignments in private and public companies. Fredrik Sjödin has a background from the American investment companies KKR and Sageview Capital as well as the investment bank Salomon Smith Barney. Fredrik Sjödin is the founder and Investment Manager of the investment company Tramontane Invest.
Other ongoing assignments:
Chairman of the Board of Kostfonden, Aktiebolaget Båstad Viktoria 50, SVFS Advisory AB, Tramontane Invest AB and Treat Lifestyle DSF AB. Board member of Garden Glory AB, Studio Sandra Sjödin AB and Maid in Båstad AB. Deputy board member of Niljon Fastigheter AB. CEO of SVFS Advisory AB.
Holdings in the Company: 1,314,626 shares and 20,000 TO 2021/2024 – B
Independent in relation to the company, company management and its major shareholders.
Born 1977. Founder. Chief Technology Officer. Board member since 2015.
Mohammad H.A. Ibrahim holds a PhD in Microbiology and Biotechnology from the University of Minster, Germany. Mohammad H.A. Ibrahim is the founder of Bioextrax and has more than 20 years experience in Research and Development of microbial production of polymers, enzymes and chemicals, publishing several scientific articles and patents. Mohammad has worked as postdoctoral researcher at Lund University, Sweden, the University of Hawaii, USA, and Rensselaer Polytechnic Institute, USA, among others.
Other ongoing assignments: Holder of the designation Moneractor AB.
Holdings in the Company: 1,958,840 shares and 300,000 TO 2023/2026.
Independent in relation to the company as well as its major owners.
Alexander Steinbüchel is a Professor at Münster University in Germany. For many years, he was Head of the Department for Molecular Microbiology and Biotechnology. Professor Steinbüchel is known as one of the founding fathers of the entire PHA industry, contributing to establishing PHA as a research area and setting the scene for commercialisation of the materials. Prior to this position, Alexander worked as an Advisor at Monsanto, today part of Bayer.
Yossi Shabtai started as Researcher at MIT and has held positions like Principal Scientist and Director of Fermentation Operation at Metabolix. The company was a pioneer in the industry and one of the, first major producers of the bioplastic PHA. Today, Yossi is a global” Thought Leader” within the PHA area.
Nicolas Nouvel has a PhD in Polymer Chemistry from Cambridge University. For the past years, he has held several senior positions within the global polymer industry, latest as Global Account Manager at Lubrizol.
Jan has held global executive R&D director positions at both Dow Chemical and DSM for 15 years across different polymer business units (engineering plastics, epoxy resins, and elastomers). He is a member of the Global Expert Team on renewable feedstock-based materials of the Nova Institute and member of the Scientific Advisory Board of the Aachen Maastricht Institute for Biomaterials. Jan is the Co-founder and Board member of the global organization for the PHA-platform: GO!PHA.
Kjell Ivar Bache has a master’s in economics from Cambridge University. He has for the past twenty years held managerial positions with the Norwegian business industry. Since 2014 he is the CEO for BioBag Group, which is a leading producer and supplier of compostable and biodegradable products. BioBag Group, headquarted in Norway, was recently acquired by Novamont.
Bioextrax patented and natural processes allow for cost-efficient production of sustainable alternatives to traditional polymers and proteins. Unlike most competing technologies our processes are 100% free of GMO and chemicals.
Bioextrax technologies help you go green while improving your bottom line. We offer licenses to our technologies for extraction of PHA biopolymers from PHA producing bacteria, production of PHA from sucrose and conversion of poultry feathers into hydrolysed protein and keratin microfibers.
Our technologies produce cost-competitive and sustainable replacements to carbon-intensive, polluting materials and protein sources. Reach out if you are interested in samples.